soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Editorial Fellow Harleen Marwah, MD, summarizes the trial. Visit NEJM.org for the full results. #ACC25 #Cardiology #ClinicalTrials #MedTok #NEJM Semaglutide reduces cardiovascular events by

We are entering a new era of obesity care where patients want individualized treatment plans that address their needs and provide choices, including oral formulations, said Anna Windle, PhD, Senior Vice President, Clinical Development, Medical & Regulatory Affairs at Novo Nordisk Inc, in a May 2, 2025, statement

What some people lose on a GLP-1 course compresses years of that process into a single treatment window

Yes, both require prescription-only medical supervision in the UK

and 4 p.m., when the sun's rays are strongest

At room temperature, the degradation of liquid IGF-1 LR3 accelerates dramatically

Because retatrutide is unlicensed, it may only be used lawfully in the UK within an authorised clinical trial (as an Investigational Medicinal Product, or IMP) or under specific MHRA-regulated frameworks for unlicensed medicines